In next-generation antibody discovery and engineering, precision is everything. Even the smallest oversight can cascade through the workflow—propagating errors, compromising data integrity, and ultimately affecting critical decisions.
This webinar brings together experts from Dotmatics, BioGlyph, and leading industry scientists to explore how achieving fidelity of precision—from sequence design to data integration—can transform antibody R&D outcomes. We’ll examine how modern platforms like Luma and BioGlyph are solving long-standing challenges in data fidelity, workflow integration, and early error detection, enabling scientists to make the best possible decisions at every stage.
Through real-world commentary from experienced researchers, we’ll highlight the practical impacts of avoiding error propagation, the value of unified data environments, and the game-changing potential of integrated discovery-to-design platforms.
- Understand the high stakes of precision in antibody discovery - Why missing small errors early can lead to costly, late-stage setbacks
- See how integrated digital platforms prevent error propagation - From format and sequence-level fidelity in BioGlyph to end-to-end workflow integration in Luma
- Learn strategies for connecting siloed data - Applying FAIR data principles and composable workflows to improve accuracy and decision-making
- Hear real-world experiences from industry scientists - The common challenges in multispecific antibody development and how better tools can change the game
- Discover the path to next-gen antibody R&D - How precise design, robust registration, and connected digital threads enable faster, better science